ArticleThe Journal of clinical investigation2022

Breast cancer cell-derived microRNA-155 suppresses tumor progression via enhancing immune cell recruitment and antitumor function.

Junfeng Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.